Serum posaconazole levels during acute myeloid leukaemia induction therapy: correlations with breakthrough invasive fungal infections
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum posaconazole levels during acute myeloid leukaemia induction therapy: correlations with breakthrough invasive fungal infections
Authors
Keywords
-
Journal
MYCOSES
Volume 58, Issue 6, Pages 362-367
Publisher
Wiley
Online
2015-04-23
DOI
10.1111/myc.12326
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic Drug Monitoring and Dose Adjustment of Posaconazole Oral Suspension in Adults With Acute Myeloid Leukemia
- (2015) Shelly E. Hummert et al. THERAPEUTIC DRUG MONITORING
- Posaconazole Tablet Pharmacokinetics: Lack of Effect of Concomitant Medications Altering Gastric pH and Gastric Motility in Healthy Subjects
- (2014) Walter K. Kraft et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal Prophylaxis with Posaconazole in Patients with Acute Myeloid Leukemia: Dose Intensification Coupled with Avoidance of Proton Pump Inhibitors Is Beneficial in Shortening Time to Effective Concentrations
- (2013) Piergiorgio Cojutti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Posaconazole Therapeutic Drug Monitoring in the Real-life Setting: A Single-Center Experience and Review of the Literature
- (2013) Barbara N. Gross et al. PHARMACOTHERAPY
- Pharmacokinetics of Different Dosing Strategies of Oral Posaconazole in Patients with Compromised Gastrointestinal Function and Who Are at High Risk for Invasive Fungal Infection
- (2012) Oliver A. Cornely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of the Practice of Antifungal Prophylaxis Use in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results From the SEIFEM 2010-B Registry
- (2012) L. Pagano et al. CLINICAL INFECTIOUS DISEASES
- Challenging Recommended Oral and Intravenous Voriconazole Doses for Improved Efficacy and Safety: Population Pharmacokinetics–Based Analysis of Adult Patients With Invasive Fungal Infections
- (2012) Andres Pascual et al. CLINICAL INFECTIOUS DISEASES
- Making sense of posaconazole therapeutic drug monitoring
- (2012) Michelle R. Ananda-Rajah et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome
- (2012) J. J. Vehreschild et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Posaconazole plasma concentrations and invasive mould infections in patients with haematological malignancies
- (2012) Martin Hoenigl et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Concentration of Antifungal Agents within Host Cell Membranes: a New Paradigm Governing the Efficacy of Prophylaxis
- (2011) P. Campoli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients
- (2011) M. Michallet et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Therapeutic drug monitoring of posaconazole in hematology adults under posaconazole prophylaxis: influence of food intake
- (2011) C. Eiden et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experience
- (2011) C. Girmenia et al. HAEMATOLOGICA
- Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period
- (2011) M. R. Ananda-Rajah et al. HAEMATOLOGICA
- Therapeutic Drug Monitoring of Posaconazole in Hematology Patients: Experience with a New High-Performance Liquid Chromatography-Based Method
- (2010) W. C. Neubauer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Intracellular Concentrations of Posaconazole in Different Compartments of Peripheral Blood
- (2010) F. Farowski et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group
- (2010) F. Lo-Coco et al. BLOOD
- Clinical pharmacodynamics and pharmacokinetics of the antifungal extended-spectrum triazole posaconazole: an overview
- (2010) Hans-Peter Lipp BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Exposure–Response of Posaconazole Used for Prophylaxis Against Invasive Fungal Infections: Evaluating the Need to Adjust Doses Based on Drug Concentrations in Plasma
- (2010) S H Jang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control study
- (2010) C. Even et al. HAEMATOLOGICA
- Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort
- (2010) J. J. Vehreschild et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Factors Influencing Pharmacokinetics of Prophylactic Posaconazole in Patients Undergoing Allogeneic Stem Cell Transplantation
- (2009) V. Kohl et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic Drug Monitoring of Posaconazole: a Monocentric Study with 54 Adults
- (2009) D. Lebeaux et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications
- (2008) D. Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
- (2008) Ben De Pauw et al. CLINICAL INFECTIOUS DISEASES
- Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
- (2007) A. Pascual et al. CLINICAL INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now